Compugen (CGEN) Shareholder's Equity Growth (3y) (2012 - 2025)
Compugen (CGEN) Shareholder's Equity Growth (3y) (2012 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Compugen |
189.59 Mn |
97.83 Mn |
352,000.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
9.77% |
| Dec 31, 2024 |
-19.86% |
| Dec 31, 2023 |
-18.20% |
| Dec 31, 2022 |
26.56% |
| Dec 31, 2021 |
42.02% |
| Jun 30, 2015 |
63.36% |
| Mar 31, 2015 |
68.10% |
| Dec 31, 2014 |
75.65% |
| Sep 30, 2014 |
68.55% |
| Jun 30, 2014 |
56.06% |
| Mar 31, 2014 |
54.85% |
| Dec 31, 2013 |
4.08% |
| Sep 30, 2013 |
0.21% |
| Jun 30, 2013 |
-7.69% |
| Mar 31, 2013 |
-8.74% |
| Dec 31, 2012 |
-13.60% |
